Year 2019 / Volume 111 / Number 8
Original
Prehabilitation in patients undergoing pancreaticoduodenectomy: a randomized controlled trial

603-608

DOI: 10.17235/reed.2019.6182/2019

Fabio Ausania, Paula Senra, Reyes Meléndez, Regina Caballeiro, Rubén Ouviña, Enrique Casal-Núñez,

Abstract
Introduction: prehabilitation has been proposed as an effective tool to prevent postoperative complications in patients undergoing major abdominal surgery. However, no studies have demonstrated its effectiveness in pancreatic surgical patients. The aim of this study was to assess the impact of prehabilitation on postoperative complications in patients undergoing a pancreaticoduodenectomy (PD). Methods: this was a randomized controlled trial. Eligible candidates who accepted to participate were randomized to the control (standard care) or intervention (standard care + prehabilitation) group. All patients with pancreatic or periampullary tumors who were candidates for pancreaticoduodenectomy were included. Patients who received neoadjuvant treatment were excluded. Prehabilitation covered three actions: a) nutritional support; b) control of diabetes and exocrine pancreatic insufficiency; and c) physical and respiratory training. The main study outcome was the proportion of patients who suffered postoperative complications. Secondary outcomes included the occurrence of specific complications (pancreatic leak and delayed gastric emptying) and hospital stay. Results: forty patients were included in the analysis. Twenty-two patients were randomized to the control arm and 18, to the intervention group. No statistically significant differences were observed in terms of overall and major complications between the prehabilitation and standard care groups. Pancreatic leak was not statistically different between the groups (11% vs 27%, p = 0.204). However, DGE was significantly lower in the prehabilitation group (5.6% vs 40.9% in the standard care group, p = 0.01). Conclusion: prehabilitation did not reduce postoperative complications following pancreaticoduodenectomy. However, a reduction in DGE was observed. Further studies are needed to validate the role and the timing of prehabilitation in high-risk patients.
Share Button
New comment
Comments
No comments for this article
References
1. Muscari F, Suc B, Kirzin S, et al. Risk factors for mortality and intra- abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 2006;139:591–8.
2. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduode- nectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10:1199–211.
3. Pitt HA, Cameron JL, Postier RG, et al. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66–71.
4. Ausania F, Snowden CP, Prentis JM, et al. Effects of low cardiopulmonary reserve on pancreatic leak following pancreaticoduodenectomy. Br J Surg. 2012 Sep;99(9):1290-4.
5. Ausania F, Vallance AE, Manas DM, et al. Double bypass for inoperable pancreatic malignancy at laparotomy: postoperative complications and long-term outcome. Ann R Coll Surg Engl. 2012 Nov;94(8):563-8.
6. Barberan-Garcia A, Ubré M, Roca J, et al. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56.
7. Moran J, Guinan E, McCormick P, et al. The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. Surgery. 2016 Nov;160(5):1189-1201.
8. Tempero MA, Malafa MP, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.
9. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002 Aug;56(8):779-85.
10. Lassen K, Coolsen MM, Slim K,; rt al. Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clin Nutr. 2012 Dec;31(6):817-30.
11. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96.
12. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017 Mar;161(3):584-591.
13. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007 Nov;142(5):761-8.
14. Sabater L, Ausania F, Bakker OJ, et al. Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg. 2016 Dec;264(6):949-958.
15. Parmar AD, Sheffield KM, Vargas GM, Pitt HA, Kilbane EM, Hall BL, Riall TS. Factors associated with delayed gastric emptying after pancreaticoduodenectomy. HPB (Oxford). 2013 Oct;15(10):763-72.
16. Jones C, Kelliher L, Dickinson M, et al. Impact of a prehabilitation program on functional status and length of stay following major pancreatic surgery with an ERAS pathwayJones.Clinical Nutrition ESPEN June 2017. Volume 19, Page 91
17. Ngo-Huang A, Parker N, Martinez V, et al. Feasibility of a Prehabilitation Program for Patients with Potentially Resectable Pancreatic Cancer: Pilot Study. PM&R September 2016Volume 8, Issue 9, Supplement, Page S183
18. Pecorelli N, Fiore JF Jr, Gillis Cet al. The six-minute walk test as a measure of postoperative recovery after colorectal resection: further examination of its measurement properties. Surg Endosc. 2016 Jun;30(6):2199-206.
19. Dalgas U, Severinsen K, Overgaard K. Relations between 6 minute walking distance and 10 meter walking speed in patients with multiple sclerosis and stroke. Arch Phys Med Rehabil. 2012 Jul;93(7):1167-72.
20. Van Tienhoven , Versteijne E, Suker M, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial. Journal of Clinical Oncology 2018 36:18_suppl, LBA4002-LBA4002
21. Sandini M, Honselmann KC, Birnbaum DJ, et al. Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter?: The FRAGERITA Study Group. Ann Surg. 2018 Nov;268(5):808-814.
22. Tilson JK, Sullivan KJ, Cen SY, et al. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2010 Feb;90(2):196-208.
23. Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J. 1965 Feb;14:61-5.
Related articles

Letter

Ischemic gastritis and severe diabetic ketoacidosis

DOI: 10.17235/reed.2020.7655/2020

Letter

Hemorrhagic complications following paracentesis

DOI: 10.17235/reed.2020.6914/2020

Original

Usefulness of an intra-gastric balloon before bariatric surgery

DOI: 10.17235/reed.2017.4624/2016

Original

Multicenter study on the safety of bariatric endoscopy

DOI: 10.17235/reed.2017.4499/2016

Letter to the Editor

Intramural gastric hematoma in the context of an acute pancreatitis

DOI: 10.17235/reed.2017.4494/2016

Citation tools
Ausania F, Senra P, Meléndez R, Caballeiro R, Ouviña R, Casal-Núñez E, et all. Prehabilitation in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. 6182/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 2195 visits.
This article has been downloaded 1347 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 19/01/2019

Accepted: 26/02/2019

Online First: 24/06/2019

Published: 31/07/2019

Article revision time: 24 days

Article Online First time: 156 days

Article editing time: 193 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology